Effect of actinomycin D on uptake and incorporation of thymidine and hypoxanthine into the acid-soluble and acid-insoluble fractions of rat hepatoma cells grown in culture.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000201:enzymology / Q000378:metabolism*; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007042:Hypoxanthines / Q000378:metabolism*; D007700:Kinetics; D008113:Liver Neoplasms / Q000201:enzymology / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000201:enzymology; D051381:Rats; D013268:Stimulation, Chemical; D013936:Thymidine / Q000378:metabolism*; D013937:Thymidine Kinase / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D007042:Hypoxanthines; D014316:Tritium; D003609:Dactinomycin; D003513:Cycloheximide; D013937:Thymidine Kinase; D013936:Thymidine; D014529:Uridine